Checchi Capital Advisers, LLC Ionis Pharmaceuticals Inc Transaction History

Checchi Capital Advisers, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$36.45 - $47.7 $154,329 - $201,961	4,234 New	4,234 $201,000
Q4 2023 Feb 07, 2024	BUY	$43.39 - $51.63 $183,713 - $218,601	4,234 New	4,234 $214,000
Q1 2021 May 10, 2021	SELL	$42.51 - $63.78 $185,726 - $278,654	-4,369 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $860 - $1,145	-19 Reduced 0.43%	4,369 $247,000
Q3 2020 Nov 10, 2020	SELL	$47.45 - $62.95 $16,133 - $21,403	-340 Reduced 7.19%	4,388 $208,000
Q2 2020 Aug 12, 2020	BUY	$46.85 - $61.05 $18,177 - $23,687	388 Added 8.94%	4,728 $279,000
Q1 2020 May 07, 2020	BUY	$41.6 - $63.4 $38,521 - $58,708	926 Added 27.12%	4,340 $205,000
Q4 2019 Feb 07, 2020	SELL	$53.85 - $65.27 $30,371 - $36,812	-564 Reduced 14.18%	3,414 $206,000
Q3 2019 Nov 06, 2019	SELL	$59.06 - $72.15 $144,047 - $175,973	-2,439 Reduced 38.01%	3,978 $238,000
Q2 2019 Aug 06, 2019	SELL	$62.09 - $86.14 $25,891 - $35,920	-417 Reduced 6.1%	6,417 $412,000
Q1 2019 May 09, 2019	BUY	$52.92 - $81.17 $23,178 - $35,552	438 Added 6.85%	6,834 $555,000
Q3 2018 Oct 29, 2018	SELL	$42.88 - $53.7 $85 - $107	-2 Reduced 0.03%	6,396 $330,000
Q2 2018 Aug 06, 2018	SELL	$40.53 - $50.7 $45,190 - $56,530	-1,115 Reduced 14.84%	6,398 $267,000
Q1 2018 May 01, 2018	SELL	$44.08 - $55.05 $218,151 - $272,442	-4,949 Reduced 39.71%	7,513 $331,000
Q4 2017 Feb 02, 2018	SELL	$50.3 - $64.39 $269,658 - $345,194	-5,361 Reduced 30.08%	12,462 $627,000
Q3 2017 Nov 02, 2017	BUY	$45.56 - $59.57 $812,015 - $1.06 Million	17,823	17,823 $904,000

414

136M

862K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.63B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Checchi Capital Advisers, LLC with notifications on news.